ROYALTY OBLIGATIONS NET (Details Narrative) - USD ($)		12 Months Ended
ROYALTY OBLIGATIONS NET (Details Narrative) - USD ($)	Jan. 03, 2022	Dec. 31, 2022	Dec. 31, 2021
Interest expense amortization		$ 477,436	$ 477,436
Non-cash interest expense		$ 7,171,200
Expected life of the arrangement		15 years
Royalty agreements description		Each party would purchase shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), in the aggregate amount of $3,000,000 at a purchase price of $15.00 per share (the “Purchase Price”), for a total of 200,000 shares of Common Stock; and (ii) the Company shall pay each (a) a total of $37.50 from the gross revenue derived from each of its weight loss treatments sold in the United States starting on the first (1st) day that the first unit of the treatment is sold (the “Initial Sales Date”) and ending on the third (3rd) anniversary of the Initial Sales Date; and (b) a total of $25.00 from the gross revenue derived from each of its weight loss treatments sold in the United States starting on the day following the third (3rd) anniversary of the Initial Sales Date and ending on the fifteenth (15th) anniversary of the Initial Sales Date (the “Royalty”).
Ownership percentage		50.00%
Minimum [Member] \| Joseph Galligan [Member]
Ownership percentage	10.00%	10.00%
Maximum [Member] \| Joseph Galligan [Member]
Ownership percentage	15.00%	15.00%